Publications by authors named "Stephane Heijmans"

Claim this Profile
L
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.
Philippe van de Borne, André Peeters, Luc Janssens, Attilio Leone, Robin Lemmens, Stéphane Heijmans

Acta Cardiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of FRAX risk factors and the osteoporosis treatment gap among women ≥ 70 years of age in routine primary care across 8 countries in Europe.
Eugene McCloskey, Jeetandera Rathi, Stephane Heijmans, Mark Blagden, Bernard Cortet

Arch Osteoporos· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine.
Marc Demeulemeester, Nathalie Lavis, Yohan Balthazar, Patrice Lechien, Stéphane Heijmans

Hum Vaccin Immunother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium.
Johan Flamaing, Wilfried De Backer, Yves Van Laethem, Stéphane Heijmans, Annick Mignon

BMC Fam Pract· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium.
Johan Flamaing, Wilfried De Backer, Yves Van Laethem, Stéphane Heijmans, Annick Mignon

BMC Fam Pract· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study.
Paul Gillard, Didier Giet, Stéphane Heijmans, Mamadou Dramé, Karl Walravens

Trials· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity profile of a 3.75-μg hemagglutinin pandemic rH5N1 split virion AS03A-adjuvanted vaccine in elderly persons: a randomized trial.
Stéphane Heijmans, Marc De Meulemeester, Paul Reynders, Didier Giet, Etienne Demanet

J Infect Dis· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.
Jiri Beran, Arvydas Ambrozaitis, Alvydas Laiskonis, Narseta Mickuviene, Patrick Bacart, Stephane Heijmans

BMC Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis